RSS

Novo REPAIR Impact Fund

UK-based biotech company Procarta Biosystems has received €1.5 million funding to help it develop novel therapies to combat antimicrobial resistance (AMR). Read more

News

Polyphor — a clinical stage Swiss biopharmaceutical company — has raised CHF 6.8 million from the Novo REPAIR Impact Fund to accelerate the development of novel antibiotics against multi-drug resistant Gram-negative pathogens. Read more

News